EODData

MEMBERSHIP REGISTER LOG IN

LSE, 0QNO: Lonza Group AG

13 Nov 2025
LAST:

553.1

CHANGE:
 1.96		OPEN:
558.4		HIGH:
558.6		ASK:
0.0		VOLUME:
113.2K
CHG(%):
0.35		PREV:
555.1		LOW:
552.4		BID:
0.0		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
13 Nov 25558.4558.6552.4553.1113.2K
12 Nov 25558.0559.6553.6555.173.6K
11 Nov 25543.4554.2538.8552.854.3K
10 Nov 25531.2537.3530.0536.321.9K
07 Nov 25536.4536.4527.8530.413.8K
06 Nov 25539.6542.4531.6533.433.6K
05 Nov 25538.2538.5529.7536.961.8K
04 Nov 25538.0540.0530.8539.382.8K
03 Nov 25556.0556.0538.6541.845.4K
31 Oct 25558.4559.6551.4553.59.9K

COMPANY PROFILE

Name:Lonza Group AG
About:Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Biologics; Small Molecules; Cell & Gene; and Capsules & Health Ingredients segments. The Biologics segment engages in the contract development and manufacturing of biopharmaceuticals for clinical and commercial manufacturing needs throughout the product lifecycle, including drug substance and drug product manufacturing. Its Small Molecules segment provides integrated development and manufacturing services for small molecule drug substances and their intermediates. This segment also supports customers across aspects of design, development, and manufacturing, such as particle engineering and drug product packaging. The Cell & Gene segment develops technologies and platforms that industrialize the manufacturing processes and production of cell and gene therapies; offers contract development and manufacturing services, and regulatory support for a range of allogeneic and autologous cell therapies, and exosome-based therapies, as well as viral vector gene therapies. This segment also provides Cocoon platform, a closed automated system for patient-scale cell therapy manufacturing; and specialty raw materials and enabling technology solutions in cell and gene therapy, injectable drugs, vaccines, and bio-manufacturing markets. Its Capsules & Health Ingredients segment offers capsules, dosage form solutions, and health ingredients for pharmaceutical and nutraceutical customers. Lonza Group AG was incorporated in 1897 and is headquartered in Basel, Switzerland.
Address:Muenchensteinerstrasse 38, Basel, Switzerland, 4002
Website:https://www.lonza.com
ISIN:CH0013841017
LEI:549300EFW4H2TCZ71055

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:0.14 
Price to Sales:5.65 
Price to Book:4.40 
Profit Margin:0.10 
Operating Margin:0.17 
Return on Assets:0.04 
Return on Equity:0.08 
EPS Ratio:39.52 
DivYield:0.01 
Div/Share:4.00 
Revenue:7.093B 
EBITDA:1.945B 
Shares:74.43M 
Market Cap:41.169B 

TECHNICAL INDICATORS

MA5:545.561.4%
MA10:543.261.8%
MA20:554.840.3%
MA50:547.581.0%
MA100:555.740.5%
MA200:561.791.6%
STO9:77.89
STO14:38.95
RSI14:30.17 
WPR14:-54.07
MTM14:-26.78
ROC14:-0.05 
ATR:11.30 
Week High:559.601.2%
Week Low:527.804.8%
Month High:588.806.4%
Month Low:518.801.6%
Year High:615.8011.3%
Year Low:468.1018.2%
Volatility:1.26 

RECENT SPLITS

Date Ratio
02 May 2017407-377

RECENT DIVIDENDS

Date Amount
13 May 2025$4.00
13 May 2024$4.00
09 May 2023$3.50
09 May 2022$3.00
10 May 2021$3.00
30 Apr 2020$2.75
24 Apr 2019$2.75
08 May 2018$2.75
27 Apr 2017$2.75
26 Apr 2016$2.50